Effects of three alkoxypsoralens on voltage gated ion channels in Ranvier nodes

General Physiology and Biophysics

Volumn 19, Issue 4, 2000, Pages 345-364

  During T ^a   Gerst, F ^b   Hansel W ^a   Wulff, H ^a   Koppenhofer E ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

Demyelinating diseases; K+ channel blockers; Node of Ranvier; Psoralens

Indexed keywords

5,8 DIETHOXYPSORALEN; BERGAPTEN; METHOXSALEN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PSORALEN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DEMYELINATING DISEASE; DEPOLARIZATION; DISSOCIATION CONSTANT; DOSE RESPONSE; DRUG EFFECT; HODGKIN HUXLEY EQUATION; NONHUMAN; PHOTOTOXICITY; POTASSIUM CURRENT; RANVIER NODE; STEADY STATE;

ANIMALS; KINETICS; MEMBRANE POTENTIALS; METHOXSALEN; NERVE FIBERS, MYELINATED; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PSORALENS; RANVIER'S NODES; SCIATIC NERVE; XENOPUS LAEVIS;

ANIMALIA;

EID: 0034441865     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Albers M., Bohuslavizki K. H., Koppenhöfer E. (1989): High standard one-loop potential clamp device for Ranvier nodes. Gen. Physiol. Biophys. 8, 409-433
2. Århem P., Frankenhaeuser B. (1974): Local anesthetics: effects on permeability properties of nodal membrane in myelinated nerve fibres from Xenopus. Potential clamp experiments. Acta physiol. scand. 91, 11-21
3. Armstrong C. M., Hille B. (1972): The inner quarternary ammonium ion receptor in potassium channels of the node of Ranvier. J. Gen. Physiol. 59, 388-400
4. Benoit E., Dubois J. M. (1987): Properties of maintained sodium current induced a toxin from Androctonus scorpion in frog node of Ranvier. J. Physiol. (London) 383, 93-114
5. Bertelsmann F. W., Polman C. H., van Diemen H. A., de Waal R., Koetsier J. C. (1992): A comparison between 4-aminopyridine and 3,4-diaminopyridine in the treatment of multiple sclerosis. Ann. Neurol. 32, P100
6. Bethge E. W., Bohuslavizki K. H., Hänsel W., Kneip A., Koppenhöfer E. (1991): Effects of some potassium channel blockers on the ionic currents in myelinated nerve. Gen. Physiol. Biophys. 10, 225-244
7. Bever, Jr. C. T. , Young D., Anderson P. A., Krumholz A., Conway K., Leslie J., Eddington N., Plaisance K. I., Panitch H. S., Dhib-Jalbut S., Fossler M. J., Devane J., Johnson K. P. (1994): The effects of 4-aminopyridine in multiple sclerosis patients: Results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial. Neurology 44, 1054-1059
8. Bohuslavizki K. H. (1989): Zur Kinetik der Natriumionenströme des Ranvierschen Schnürrings unter optimierten Messbedingungen. Thesis. University of Kiel, Medical Faculty
9. Bohuslavizki K. H., Hänsel W., Kneip A., Koppenhöfer E., Reimers A. (1992): Potassium channel blockers from Ruta - a new approach for the treatment of multiple sclerosis. Gen. Physiol. Biophys. 11, 507-512
10. Bohuslavizki K. H., Hänsel W., Kneip A., Koppenhöfer E., Reimers A., Sanmann K. (1993a): Blocking of potassium channels in Ranvier nodes by 4,5,6,7-substituted benzofurans and its significance on demyelinating diseases. Gen. Physiol. Biophys. 12, 293-301
11. Bohuslavizki K. H., Hinck-Kneip Ch., Kneip A., Koppenhöfer E., Reimers, A. (1993b): Reduction of MS-related scotomata by a new class of potassium channel blockers from Ruta graveolens. Neuro-ophthalmol. 13, 191-198
12. Bohuslavizki K. H., Hänsel W., Kneip A., Koppenhöfer E., Niemöller E., Sanmann K. (1994a): Mode of action of psoralens, benzofurans, acridinons, and coumarins on the ionic currents in intact myelinated nerve fibres and its significance in demyelinating diseases. Gen. Physiol. Biophys. 13, 309-328
13. Bohuslavizki K. H., Kneip A., Koppenhöfer E. (1994b): State-of-the-art potential clamp device for myelinated nerve fibres using a new versatile input probe. Gen. Physiol. Biophys. 13, 357-376
14. Brismar T., Schwarz J. R. (1985): Potassium permeability in rat myelinated nerve fibres. Acta physiol. scand. 124, 141-148
15. Bünger A., Erbersdobler H. F., Gerst F., Grunwald G., Koppenhöfer E. (1996): Erfahrungen mit einer psoralenreichen Diät bei multipler Sklerose (1996): Akt. Ernähr.-Med. 21, 229-234
16. Chandy K. G., Gutman G. A. (1995): Voltage-gated potassium channel genes. In: Handbook of Receptors and Channels (Ed. R. A. North) pp. 1-71, CRC press, Boca Raton, Florida
17. van Diemen H. A., Polman C. H., van Dongen T. M., van Loenen A. C., Nauta J. J., Taphoorn M. J., van Walbeek H. K., Koetsier J. C. (1992): The effect of 4-aminopyridine on clinical signs in multiple sclerosis: A randomized, placebo-controlled, double-blind, cross-over study. Ann. Neurol. 32, 123-130
18. van Diemen H. A., Polman C. H., Koetsier J. C., van Loenen A. C., Nauta J. J., Bertelsmann F. W. (1993a): 4-Aminopyridine in patients with multiple sclerosis: dosage and serum level related to efficacy and safety. Clin. Neuropharmacol. 16, 195-204
19. van Diemen H. A. M., Polman C. H., van Dongen M. M., Nauta J. J., Strijers R. L., van Loenen A. C., Bertelsmann F. W., Koetsier J. C. (1993b): 4-aminopyridine induces functional improvement in multiple sclerosis patients: a neurophysiological study. J. Neurol. Sci. 116, 220-226
20. Dubois J. M. (1981): Evidence for the existence of three types of potassium channels in the frog Ranvier node membrane. J. Physiol. (London) 318, 297-316
21. + currents in frog myelinated nerve fibres as revealed by 4-aminopyridine. In: Aminopyridines and Similarly Acting Drugs (Eds. P. Lechat, S. Thesleff and W. C. Bowman), pp. 43-51, Pergamon Press, Oxford
22. Elinder F., Århem P. (1997): Tail currents in the myelinated axon of Xenopus laevis suggests a two-open-state Na channel. Biophys. J. 73, 179-185
23. Frankenhaeuser B. (1959): Steady state inactivation of sodium permeability in myelinated nerve fibres of Xenopus laevis. J. Physiol. (London) 148, 671-676
24. Frankenhaeuser B. (1960): Quantitative description of sodium currents in myelinated nerve fibres of Xenopus laevis. J. Physiol. (London) 151, 491-501
25. Frankenhaeuser B. (1962): Potassium permeability in myelinated nerve fibres of Xenopus laevis. J. Physiol. (London) 160, 54-61
26. Frankenhaeuser B. (1963a): A quantitative description of potassium currents in myelinated nerve fibres of Xenopus laevis. J. Physiol. (London), 169, 424-430
27. Frankenhaeuser B. (1963b): Inactivation of the sodium-carrying mechanism in myelinated nerve fibres of Xenopus laevis. J. Physiol. (London) 169, 445-451
28. Frankenhaeuser B., Huxley A. F. (1964): The action potential in the myelinated nerve fibre of Xenopus laevis as computed on the basis of voltage clamp data. J. Physiol. (London) 171, 302-315
29. Gerst F. (1997): Psoralene zur symptomatischen Therapie MS-bedingter Funktionsausfälle - Vorarbeiten für künftige klinische Studien. Thesis. University of Kiel, Medical Faculty
30. Herold M., Berney B., Angigbard D., le Duc R. (1981): Toxicological study of the compound 5-methoxy-psoralen (5-MOP). In: Psoralens in Cosmetics and Dermatology (Eds. J. Cahn, P. Forlot, C. Grupper, A. Maybeck and F. Urbach) pp. 303-309, Pergamon Press, New York
31. Jedicke U., Haller R., Koppenhöfer E. (1988): Wirkung von Aminobenzoesäure-Derivaten auf die Ionenströme myelinisierter Nervenfasern. 1. Mitteilung: Dosis-Wirkungs-Beziehungen. Arzneim.-Forsch./Drug Res. 38 (I), 801-805
32. Jones R. E., Heron J. R., Foster D. H., Snelgar R. S., Mason R. J. (1983): Effects of 4-aminopyridine in patients with multiple sclerosis. J. Neurol. Sci. 60, 353-362
33. Kniffki K. D., Siemen D., Vogel W. (1981): Development of sodium permeability inactivation in nodal membranes. J. Physiol. (London) 313, 37-48
34. Koh D. S., Jonas P., Bräu M., Vogel W. (1992): A TEA-insensitive flickering potassium channel active around the the resting potential in myelinated nerve. J. Membrane Biol. 130, 149-162
35. Koppenhöfer E. (1967): Die Wirkung von Tetraäthylammoniumchlorid auf die Membranströme Ranvierscher Schimmlige von Xenopus laevis. Pflügers Arch. 293, 34-55
36. Koppenhöfer E., Sommer R. G., Froese U. (1987): Effects of benzocaine and its isomers on sodium permeability and steady state sodium inactivation in the myelinated nerve, obtained by an improved dissection technique. Gen. Physiol. Biophys. 6, 209-222
37. Koppenhöfer E., Ditzen G., Gerst F., Reimers A. (1995): Kaliumkanalblocker in der Neurologie. TW Neurologie Psychiatrie 9, 585-591
38. Lewis R. S., Cahalan M. D. (1995): Potassium and calcium channels in lymphocytes. Annu. Rev. Immunol. 13, 623-653
39. Mortazawi S. M. A. (1972): Meladinine und U.V.A. bei Vitiligo, Psoriasis, Parapsonasis und Akne vulgaris. Derm. Mschr. 158, 908-909
40. Musajo L., Rodighiero G., Dall'Acqua F. (1965): Evidence of photoreaction of the photosensitizer furocoumarin with DNA and with pyrimidine nucleosides and nucleotides. Experientia 21, 24-25
41. Neumcke B., Nonner W., Stämpfli R. (1976): Asymmetrical displacement current and its relation with the activation of sodium current in the membrane of frog myelinated nerve. Pflügers Arch. 363, 193-203
42. Pfaffendorf M. (1986): Observations on the coupling between receptor occupation and different consecutive effects. Naunyn-Schmiedeberg's Arch. Pharmacol. 332 (suppl.), R2
43. Polman C. H., Bertelsmann F. W., de Waal R., van Diemen H. A., Uitdehaag B. M., van Loenen A. C., Koetsier J. C. (1994): 4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis. Arch. Neurol. 51, 1136-1139
44. Potter P. J., Hayes K. C., Hsieh J. T., Delaney G. A., Segal J. L. (1998): Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine: three cases. Spinal-Cord 36, 147-155
45. Raine C. S., Cross A. H. (1989): Axonal dystrophy as a consequence of long-term demyelination. Lab. Invest. 60, 714-725
46. Reid G., Scholz A., Bostock H., Vogel W. (1999): Human axons contain at least five types of voltage dependent potassium channel. J. Physiol. (London) 518, 681-696
47. Sachs L. (1984): Applied statistics. A Handbook of Techniques. Springer, New York
48. Safronov B. V., Kampe K., Vogel W. (1993): Single voltage dependent potassium channels in rat peripheral nerve membrane. J. Physiol. (London) 460, 675-691
49. Scholz A., Reid G., Vogel W., Bostock H. (1993): Ion channels in human axons. J. Neurophysiol. 70, 1274-1279
50. Schönle Ch., Koppenhöfer E. (1983): Zur Selektivität der Wirkung gereinigten Tetraethylammoniumchlorids am Ranvierschen Schnürrings. Funkt. Biol. Med. 2, 49-52
51. Schwarz J. R., Reid G., Bostock H. (1995): Action potentials and membrane currents in the human node of Ranvier. Pflügers Arch. 430, 283-292
52. Schwid S. R., Petrie M. D., McDermott M. P., Tierney D. S., Mason D. H., Goodman A. D. (1997): Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurology 48, 817-821
53. Scolding N., Franklin R. (1998): Axon loss in multiple sclerosis. The Lancet 352, 340-341
54. Sherrat R. M., Bostock H., Sears T. A. (1980): Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres. Nature 283, 570-572
55. Smith K. J., Felts P. A., John G. R. (2000): Effects of 4-aminopyridine. Brain 123, 171-184
56. Stämpfli R., Hille B. (1976): Electrophysiology of the peripheral myelinated nerve. In: Frog Neurobiology (Eds. R. Llinas and W. Precht) pp. 3-32, Springer, Berlin
57. Stefoski D., Davis F. A., Faut M., Schauf C. L. (1987): 4-Aminopyridine improves clinical signs in multiple sclerosis. Ann. Neurol. 21, 71-77
58. Stefoski D., Davis F. A., Fitzsimmons W. E., Luskin S. S., Rush J., Parkhurst G. W. (1991): 4-Aminopyridine in multiple sclerosis: prolonged administration. Neurology 41, 1344-1348
59. Šztengl M., Pučelík P. (1999): Effects of strontium ions on contraction and action potential in rabbit papillary muscles. A comparison with effects of tetraethylammonium ions. Gen. Physiol. Biophys. 18, 19-33
60. Stern R. S., Khanh T. N., Väkevä L. H. (1997): Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N. Engl. J. Med. 336, 1041-1045
61. Trapp B. D., Peterson J., Ransohoff R. M., Rudick R., Mörk S., Bö L. (1998): Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278-285
62. Ulbricht W., Wagner H. H., Schmidtmayer J. (1982): Effects of aminopyridines on potassium currents of the nodal membrane. In: Aminopyridines and Similarly Acting Drugs (Eds. P. Lechât, S. Thesleff and W. C. Bowman), pp. 29-41, Pergamon Press, Oxford
63. + channels in terminal and juxtaparanodal regions of neurons. Nature 365, 75-79
64. Waxman S. G. (1987): Conduction properties and pathophysiology of myelinated and nonmyelinated nerve fibers. In: Handbook of Clinical Neurology, Vol. 7 (51), Neuropathies (Ed. W. B. Matthews), pp. 41-62, Elsevier, Amsterdam
65. Waxman S. G. (1998): Demyelinating diseases - new pathological insights, new therapeutic targets. N. Engl. J. Med. 338, 323-324
66. Wiese H., Koppenhöfer E. (1988): Minimizing the influence of the series resistance in potential clamped Ranvier nodes. Gen. Physiol. Biophys. 7, 143-156
67. Wulf H. Ch. (1982): Aspects of the toxicology of 8-methoxypsoralen and longwave ultraviolet light. Acta Dermato-Venereologica, suppl. 106, The Finsen Institute, Copenhagen
68. Wulff H., Koppenhöfer E., Hänsel W. (1998a): Potassium channel blocking psoralens, benzofurans, acridones and coumarins for the treatment of multiple sclerosis and related diseases. Curr. Res. Ion Channel Modulators 3, 207-212
69. + channels: synthesis and photoreactivity. J. Med. Chem. 41, 4542-4549
70. Zaciu C., Koppenhöfer E., Maskaliunas R (1996): Reliability of ionic current measurements in Ranvier nodes. Gen. Physiol. Biophys. 15, 89-107
71. Zajdela F., Bisagni E. (1981): 5-Methoxypsoralen, the melanogenic additive in sun-tan preparations is tumorigenic in mice exposed to 365 nm u. v. radiation. Carcinogenesis 2, 121-127
72. Zhou L., Messing A., Chiu S. Y. (1999): Determinants of excitability at transition zones in Kv 1.1-deficient myelinated nerves. J. Neurosci. 19, 5768-5781